Topic: What are the most promising approaches for beta cell replacement moving forward? Anchors: Doug Melton PhD (HSCI), Ali Naji MD PhD (PENN), Mike Rickles MD (PENN), Felicia Pagliuca PhD (Vertex) Matthias Hebrok PhD, (UCSF) Panel: Jon Odorico MD (U Wisc), Pete Butler MD (UCLA) Cherie Stabler, PhD (UF), Mark Atkinson, PhD (UF), Ekaterine Bershivili MD PhD (UGeneva) WHAT: State of the Science is an interactive conversation with room for granular and lively debate focused on the most pressing issues in type 1 diabetes (T1D) research. Our goal is to foster open science, interaction, and collaboration–all hallmarks of the(sugar)science mission. These virtual conversations will involve: 30 minute introduction – What’s HOT in this field? Describing the state of the art. 20 minute panel interface – What does the future hold? 10 minutes – Audience Q/A WHO: Anchors (2) – introduce the topic, state of the art, and what’s happening in the field Panelists (3) – debate current hypotheses and postulate what the future folds Audience (50-100) – contribute meaningful questions and insights Link to our page: https://thesugarscience.org/state-of-...

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related